Notwithstanding the medium-term gains, the acquisition of JB Chemicals & Pharmaceuticals brings uncertainty over successful integration and generation of synergies.

Stocks to Watch today, Monday, June 30, 2025: Markets edged higher on Friday, extending the ongoing uptrend and ending the session with modest gains. In today’s trade, shares of Torrent Pharma, Tata ...

Torrent will initially acquire 46.39% of JB Pharma for Rs 11,917 crore through a share purchase agreement at Rs 1,600 per share.

Torrent Pharma's Rs 11,917 crore stake buy from KKR and Rs 1,639/share open offer draws mixed analyst reactions; stock holds steady amid valuation and leverage discussions.

Total Deal Size Estimated at ₹19,500 crore, making it the second-largest acquisition in India’s pharma industry.

India's Second Most Valued Pharma To Be: Torrent Pharmaceuticals Acquires ₹19,500-Crore Majority Stake In JB Chemicals "Torrent Pharmaceuticals Limited and global investment firm KKR today ...

Torrent Pharma to acquire J.B. Chemicals & Pharma for equity valuation of ₹25,689 crore This strategic alignment furthers our goal of strengthening our presence in the Indian pharma market, says ...

Torrent Pharmaceuticals has announced acquisition of a controlling stake in JB Chemicals & Pharmaceuticals Ltd from New York-based global investment firm KKR, with plans to merge the two entities ...

Torrent Pharmaceuticals to acquire 46.39% stake in JB Chemicals and Pharmaceuticals, merging to strengthen global presence.

Torrent will buy a 46.4 per cent stake in the company known as JB Pharma from KKR for 1,600 rupees per share, according to a statement on Sunday (Jun 29), amounting to about US$1.4 billion. Torrent ...

The deal grants Torrent Pharma access to a thriving pharmaceutical business. JB Pharma makes drugs for gastroenterology, hypertension, dermatology and diabetes.